Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study

R. Becker; S.D. Berkowitz; G. Breithardt; R.M. Califf; K. Fox; W. Hacke; J. Halperin; Graeme Hankey; K. Mahaffey; C. Nessel; D. Singer

doi:10.1016/j.ahj.2009.11.025

Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study

R. Becker, S.D. Berkowitz, G. Breithardt, R.M. Califf, K. Fox, W. Hacke, J. Halperin, Graeme Hankey, K. Mahaffey, C. Nessel, D. Singer

Research output: Contribution to journal › Article › peer-review

418 Citations (Scopus)

Original language	English
Pages (from-to)	340-347
Journal	American Heart Journal
Volume	159
DOIs	https://doi.org/10.1016/j.ahj.2009.11.025
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ahj.2009.11.025

Cite this

Becker, R., Berkowitz, S. D., Breithardt, G., Califf, R. M., Fox, K., Hacke, W., Halperin, J., Hankey, G., Mahaffey, K., Nessel, C., & Singer, D. (2010). Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study. American Heart Journal, 159, 340-347. https://doi.org/10.1016/j.ahj.2009.11.025

@article{84aba136b39140fa86a39086b004c664,

title = "Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study",

author = "R. Becker and S.D. Berkowitz and G. Breithardt and R.M. Califf and K. Fox and W. Hacke and J. Halperin and Graeme Hankey and K. Mahaffey and C. Nessel and D. Singer",

year = "2010",

doi = "10.1016/j.ahj.2009.11.025",

language = "English",

volume = "159",

pages = "340--347",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier - Mosby",

}

Becker, R, Berkowitz, SD, Breithardt, G, Califf, RM, Fox, K, Hacke, W, Halperin, J, Hankey, G, Mahaffey, K, Nessel, C & Singer, D 2010, 'Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study', American Heart Journal, vol. 159, pp. 340-347. https://doi.org/10.1016/j.ahj.2009.11.025

Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study. / Becker, R.; Berkowitz, S.D.; Breithardt, G. et al.
In: American Heart Journal, Vol. 159, 2010, p. 340-347.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial fibrillation: rationale and Design of the ROCKET AF study

AU - Becker, R.

AU - Berkowitz, S.D.

AU - Breithardt, G.

AU - Califf, R.M.

AU - Fox, K.

AU - Hacke, W.

AU - Halperin, J.

AU - Hankey, Graeme

AU - Mahaffey, K.

AU - Nessel, C.

AU - Singer, D.

PY - 2010

Y1 - 2010

U2 - 10.1016/j.ahj.2009.11.025

DO - 10.1016/j.ahj.2009.11.025

M3 - Article

SN - 0002-8703

VL - 159

SP - 340

EP - 347

JO - American Heart Journal

JF - American Heart Journal

ER -